Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology

References

• Altenberg B, Greulich KO. (2004). Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics, 84, 1014–1020.
   PubMed Web of Science ®Google Scholar
• Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM. (2012). Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. Cancer Res, 72, 1935–1942.
   PubMed Web of Science ®Google Scholar
• Baasiri RA, Glasser SR, Steffen DL, Wheeler DA. (1999). The breast cancer gene database: a collaborative information resource. Oncogene, 18, 7958–7965.
   PubMed Web of Science ®Google Scholar
• Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, Ong CN, Cheah PY, Eu KW, Hew CL. (2006). Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics, 5, 1119–1130.
   PubMed Web of Science ®Google Scholar
• Bonofiglio D, Aquila S, Catalano S, Gabriele S, Belmonte M, Middea E, Qi H, Morelli C, Gentile M, Maggiolini M, Andò S. (2006). Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells. Mol Endocrinol, 20, 3083–3092.
   PubMed Web of Science ®Google Scholar
• Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F. (2008). Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature, 456, 350–356.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Singh DP, Heese O, Godbole MM, Sinohara T, Black PM, Brown EM. (2000). Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis. J Neurosci Res, 61, 67–74.
   PubMed Web of Science ®Google Scholar
• Cossarizza A, Ceccarelli D, Masini A. (1996). Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. Exp Cell Res, 222, 84–94.
   PubMed Web of Science ®Google Scholar
• Crowe DL, Chandraratna RA. (2004). A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res, 6, R546–R555.
   PubMed Web of Science ®Google Scholar
• Dreszer TR, Karolchik D, Zweig AS, Hinrichs AS, Raney BJ, Kuhn RM, Meyer LR, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, Pohl A, Malladi VS, Li CH, Learned K, Kirkup V, Hsu F, Harte RA, Guruvadoo L, Goldman M, Giardine BM, Fujita PA, Diekhans M, Cline MS, Clawson H, Barber GP, Haussler D, James Kent W. (2012). The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res, 40, D918–D923.
   PubMed Web of Science ®Google Scholar
• Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. (1992). Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 68, 879–887.
   PubMed Web of Science ®Google Scholar
• Du P, Feng G, Flatow J, Song J, Holko M, Kibbe WA, Lin SM. (2009). From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics, 25, i63–i68.
   PubMed Web of Science ®Google Scholar
• Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Fenner M, Possinger K, Koeffler HP. (2002). Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat, 74, 155–165.
   PubMed Web of Science ®Google Scholar
• Gaci O. (2010). A topological description of hubs in amino Acid interaction networks. Adv Bioinformatics, 257512.
   PubMedGoogle Scholar
• Gervois P, Chopin-Delanno S, Fadel A, Dubois G, Kosykh V, Fruchart J, Najib J, Laudetand V. (1999). Bart staels fibrates increase human REV-ERBα expression in liver via a novel peroxisome proliferator-activated receptor response element. Mol Endocrin 13, 400.
   PubMed Web of Science ®Google Scholar
• Grommes C, Landreth GE, Heneka MT. (2004). Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol, 5, 419–429.
   PubMed Web of Science ®Google Scholar
• Houseknecht KL, Cole BM, Steele PJ. (2002). PPAR and its ligands: a review. Domest Anim Endocrinol, 22, 1–23.
   PubMed Web of Science ®Google Scholar
• Huang JW, Shiau CW, Yang YT, Kulp SK, Chen KF, Brueggemeier RW, Shapiro CL, Chen CS. (2005). Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol Pharmacol, 67, 1342–1348.
   PubMed Web of Science ®Google Scholar
• Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, Cejas P, Hardisson D, Fresno Vara JA, Belda-Iniesta C, González-Barón M, Cuezva JM. (2005). Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis, 26, 2095–2104.
   PubMed Web of Science ®Google Scholar
• Issemann I, Green S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645–650.
   PubMed Web of Science ®Google Scholar
• Jennifer CC, Church FC. (2011). Peroxisome proliferator-activated receptor-γ ligands alter breast cancer cell motility through modulation of the plasminogen activator system. J Oncology, 594258.
   Google Scholar
• Jiang K, He B, Lai L, Chen Q, Liu Y, Guo Q, Wang Q. (2012). Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2. Int J Mol Med, 30, 302–308.
   PubMed Web of Science ®Google Scholar
• Jiao X, Sherman BT, Huang da W, Stephens R, Baseler MW, Lane HC, Lempicki RA. (2012). DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics, 28, 1805–1806.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA, 91, 7355–7359.
   PubMed Web of Science ®Google Scholar
• Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M. (2003). Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res, 63, 5926–5939.
   PubMed Web of Science ®Google Scholar
• Lemay DG, Hwang DH. (2006). Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res, 47, 1583–1587.
   PubMed Web of Science ®Google Scholar
• Lin MS, Chen WC, Bai X, Wang YD. (2007). Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. J Dig Dis, 8, 82–88.
   PubMed Web of Science ®Google Scholar
• Martin DS, Bertino JR, Koutcher JA. (2000). ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res, 60, 6776–6783.
   PubMed Web of Science ®Google Scholar
• Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. (1999). PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol, 19, 546–551.
   PubMed Web of Science ®Google Scholar
• Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD. (2000). Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res, 46, 126–138.
   PubMed Web of Science ®Google Scholar
• Mazurek S. (2012). Pyruvate kinase M2: A key enzyme of the tumor metabolome and its medical relevance. Biomed Res, 23, 133–142.
   Web of Science ®Google Scholar
• Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. (2012). ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol, 138, 501–511.
   PubMed Web of Science ®Google Scholar
• Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. (2010). PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res, 38, D204–D210.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Das SK, Mukherjee S. (2004). Expression of Mn-Superoxide Dismutase Gene in Nontumorigenic and Tumorigenic Human Mammary Epithelial Cells. J Biomed Biotechnol, 2004, 195–202.
   PubMedGoogle Scholar
• Panasyuk G, Espeillac C, Chauvin C, Pradelli LA, Horie Y, Suzuki A, Annicotte JS, Fajas L, Foretz M, Verdeguer F, Pontoglio M, Ferré P, Scoazec JY, Birnbaum MJ, Ricci JE, Pende M. (2012). PPAR? contributes to PKM2 and HK2 expression in fatty liver. Nat Commun, 3, 672.
   PubMed Web of Science ®Google Scholar
• Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. (2001). Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol, 11, 764–768.
   PubMed Web of Science ®Google Scholar
• Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH. (2006). Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer, 5, 64.
   PubMed Web of Science ®Google Scholar
• Reddy JK, Mannaerts GP. (1994). Peroxisomal lipid metabolism. Annu Rev Nutr, 14, 343–370.
   PubMed Web of Science ®Google Scholar
• Reers M, Smith TW, Chen LB. (1991). J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry, 30, 4480–4486.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. (2000). Transcriptional regulation of adipogenesis. Genes Dev, 14, 1293–1307.
   PubMed Web of Science ®Google Scholar
• Rubin GL, Zhao Y, Kalus AM, Simpson ER. (2000). Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res, 60, 1604–1608.
   PubMed Web of Science ®Google Scholar
• Rubin GL, Zhao Y, Kalus AM, Simpson ER. (2000). Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res, 60, 1604–1608.
   PubMed Web of Science ®Google Scholar
• Scardoni G, Petterlini M, Laudanna C. (2009). Analyzing biological network parameters with CentiScaPe. Bioinformatics, 25, 2857–2859.
   PubMed Web of Science ®Google Scholar
• Smith A, Muscat G. (2006). Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. Am J Physiol Cell Physiol, 291, C203–C217.
   PubMed Web of Science ®Google Scholar
• Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, Nixon J, Van Auken K, Wang X, Shi X, Reguly T, Rust JM, Winter A, Dolinski K, Tyers M. (2011). The BioGRID Interaction Database: 2011 update. Nucleic Acids Res, 39 (database issue), D698–D704.
   Web of Science ®Google Scholar
• Stelzer G, Dalah I, Stein TI, Satanower Y, Rosen N, Nativ N, Oz-Levi D, Olender T, Belinky F, Bahir I, Krug H, Perco P, Mayer B, Kolker E, Safran M, Lancet D. (2011). In-silico human genomics with GeneCards. Hum Genomics, 5, 709–717.
   PubMedGoogle Scholar
• Tennant DA, Durán RV, Gottlieb E. (2011). Targeting metabolic transformation for cancer therapy. Nat Rev Cancer, 10, 267–277.
   Web of Science ®Google Scholar
• Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, Eardley I, Selby PJ, Banks RE. (2003). Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics, 3, 1620–1632.
   PubMed Web of Science ®Google Scholar
• Venkatachalam G, Kumar AP, Sakharkar KR, Thangavel S, Clement MV, Sakharkar MK. (2011). PPAR? disease gene network and identification of therapeutic targets for prostate cancer. J Drug Target, 19, 781–796.
   PubMed Web of Science ®Google Scholar
• Venkatachalam G, Kumar AP, Yue LS, Pervaiz S, Clement MV, Sakharkar MK. (2009). Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human. BMC Genomics, 10, S5–S10.
   PubMedGoogle Scholar
• Warburg O. (1956). On respiratory impairment in cancer cells. Science, 124, 269–270.
   PubMed Web of Science ®Google Scholar
• Yeung N, Cline MS, Kuchinsky A, Smoot ME, Bader GD. (2008). Exploring biological networks with Cytoscape software. Curr Protoc Bioinformatics, Chapter 8, Unit 8.13.
   PubMedGoogle Scholar
• Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK. (1993). Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem, 268, 26817–26820.
   PubMed Web of Science ®Google Scholar